Drug · DIN 02529815
PLERIXAFOR INJECTION
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 31, 2023; first marketed August 31, 2023.
- Drug Identification Number (DIN)
- 02529815
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Plerixafor L03AX16
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PLERIXAFOR | 20 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 19, 2022: NOC 28790Abbreviated New Drug Submission (ANDS)
Other DINs named PLERIXAFOR INJECTION
- DIN 02539454 · Marketed
- DIN 02490846 · Approved